A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Part of paid clinical trials in Glendale, California.
- Sponsor
- Kodiak Sciences Inc
- Study ID
- NCT07734844
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Diabetic Macular Edema (DME)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tabirafusp tedromer — DRUGIntravitreal injection
- Aflibercept (2.0 mg) — DRUGIntravitreal injection
Study Details
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO
Key Dates
- First listed
- Jul 29, 2026
- Start date
- Aug 3, 2026
- Status verified
- Aug 2026
- Primary completion
- Aug 31, 2028
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 910 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Tabirafusp tedromer 5 mg Q8WIntravitreal injection of tabirafusp tedromer once every 4 weeks for 6 monthly doses followed by every-8-week dosing with additional individualized dosing (up to monthly dosing)
- Experimental: Tabirafusp tedromer 5 mg Q4-24WIntravitreal injection of tabirafusp tedromer once every 4 weeks for 6 monthly doses followed by individualized dosing every 4 to 24 weeks.
- Active Comparator: Aflibercept 2 mgIntravitreal injection of aflibercept once every 4 weeks for 5 monthly doses followed by every-8-week dosing
Primary Outcome Measure
Best corrected visual acuity (BCVA) [ Time Frame: Week 52 ]
Central Contacts
- Kodiak Sciences Inc6502810850
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Kodiak Research Center | Glendale | California | 91204 | - |
| Kodiak Research Center | Pasadena | California | 91107 | - |
| Kodiak Research Center | St. Petersburg | Florida | 33711 | - |
| Kodiak Research Center | Hagerstown | Maryland | 21740 | - |
| Kodiak Research Center | Saint Louis Park | Minnesota | 55416 | - |
| Kodiak Research Center | Beaufort | South Carolina | 29902 | - |
| Kodiak Research Center | Charleston | South Carolina | 29414 | - |
| Kodiak Research Center | Ladson | South Carolina | 29456 | - |
| Kodiak Research Center | West Columbia | South Carolina | 29169 | - |
Find similar trials in Glendale, CA
Related Studies
- High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous VitrectomyPHASE4 · Recruiting · Retina Consultants of Orange County · Fullerton, California
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEPHASE3 · Recruiting · EyePoint Pharmaceuticals, Inc. · Gilbert, Arizona
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEPHASE3 · Recruiting · EyePoint Pharmaceuticals, Inc. · Bakersfield, California
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas